Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
Sally J. Adua, Anna Arnal Estape, Minghui Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Immunotherapy: an emerging modality to checkmate brain metastasis
Aatiya Ahmad, Parvez Κhan, Asad Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Choroid plexus mast cells drive tumor-associated hydrocephalus
Yiye Li, Can Di, Shi‐Jian Song, et al.
Cell (2023) Vol. 186, Iss. 26, pp. 5719-5738.e28
Closed Access | Times Cited: 17
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives
Ka Zhang, Yiwen Zhu, Ao-Qi Tang, et al.
Translational Oncology (2025) Vol. 52, pp. 102272-102272
Open Access
Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway
Xuedan Han, Jialei Liu, Yidong Zhang, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100984-100984
Open Access | Times Cited: 3
Morphological and molecular preservation through universal preparation of fresh-frozen tissue samples for multimodal imaging workflows
Andreas Dannhorn, Emine Kazanç, Lucy Flint, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2685-2711
Closed Access | Times Cited: 3
Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma
Heming Zhou, Chen Da-hong, Wenjing Diao, et al.
Experimental Cell Research (2024) Vol. 436, Iss. 1, pp. 113956-113956
Open Access | Times Cited: 2
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC
Judith L. Gulikers, G. Veerman, M. Jebbink, et al.
JTO Clinical and Research Reports (2024) Vol. 5, Iss. 4, pp. 100656-100656
Open Access | Times Cited: 1
Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer
Lin Cao, Zhiyan Qin, Ting Yu, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116207-116207
Closed Access | Times Cited: 1
RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential
Yidi Ning, Minying Zheng, Yue Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target
Hua Wang, Shijie Tang, Qibiao Wu, et al.
National Science Review (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 1
Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis
Yufan Xiang, Zhiqian Li, Dayi Pan, et al.
Small Structures (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 2
From pre-clinical to translational brain metastasis research: current challenges and emerging opportunities
Emilija Aleksandrovic, Siyuan Zhang, Dihua Yu
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 3, pp. 187-198
Open Access
Synthesis and in vitro evaluation of benzo[b]thiophene-3-carboxylic acid 1,1-dioxide derivatives as anticancer agents targeting the RhoA/ROCK pathway
Jinhao Liang, Jin Huang, Jianzhan Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: a literature review
Ioannis Georgakopoulos, Vassilis Kouloulias, George Ntoumas, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104520-104520
Closed Access
EGFR mutations in patients with lung adenocarcinoma and malignant pleural effusion: a propensity score-matched analysis of a single-center database
Qiwei Yang, Ziyi Wang, Qiang Fu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 9, pp. 2435-2447
Open Access
Acquisition and reversal of glioblastoma chemoresistance are mediated by the Rho GTPase pathway
Yuli Thamires Magalhães, Viktor Kalbermatter Boell, Fábio Luís Forti
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical Response to Osimertinib in a Non-Small-Cell Lung Cancer Patient With EGFR L833V/H835L Mutations: A Case Report
Jowan Al‐Nusair, Reesha Bodiwala, Kemnasom Nwanwene, et al.
Journal of Investigative Medicine High Impact Case Reports (2024) Vol. 12
Open Access
OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-Glycosylation
Marta Baro, Hojin Lee, Vanessa Kelley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity
Dillon P. Boulton, Connor J. Hughes, Valentina Vaira, et al.
Cell Reports (2024) Vol. 44, Iss. 1, pp. 115120-115120
Closed Access
Identifying the cancer-associated fibroblast signature to predict the prognosis and immunotherapy response in patients with lung squamous cell carcinoma
Yinhui Zhu, Yingqun Zhu, Sirui Chen, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2023), pp. 1-11
Closed Access
Page 1

Scroll to top